22 results on '"Kiesecker C"'
Search Results
2. Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein
- Author
-
Gierten, J, Ficker, E, Bloehs, R, Schlömer, K, Kathöfer, S, Scholz, E, Zitron, E, Kiesecker, C, Bauer, A, Becker, R, Katus, H A, Karle, C A, and Thomas, D
- Published
- 2008
- Full Text
- View/download PDF
3. 350 Inhibition of heteromeric Kir2.x channels by proteinkinase C dependent phosphorylation
- Author
-
Kiesecker, C., primary, Zitron, E., additional, Scherer, D., additional, Kathofer, S., additional, Thomas, D., additional, Kreye, V.A.W., additional, Schoels, W., additional, and Karle, C.A., additional
- Published
- 2005
- Full Text
- View/download PDF
4. 349 Differential regulation of Kir2.x channels by alpha-1a adrenergic receptors
- Author
-
Kiesecker, C., primary, Zitron, E., additional, Scherer, D., additional, Kathofer, S., additional, Thomas, D., additional, Kreye, V.A.W., additional, Schoels, W., additional, and Karle, C.A., additional
- Published
- 2005
- Full Text
- View/download PDF
5. QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids.
- Author
-
Zitron E, Scholz E, Owen RW, Lück S, Kiesecker C, Thomas D, Kathöfer S, Niroomand F, Kiehn J, Kreye VAW, Katus HA, Schoels W, Karle CA, Zitron, Edgar, Scholz, Eberhard, Owen, Robert W, Lück, Sonja, Kiesecker, Claudia, Thomas, Dierk, and Kathöfer, Sven
- Published
- 2005
6. Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.
- Author
-
Scherer D, von Löwenstern K, Zitron E, Scholz EP, Bloehs R, Kathöfer S, Thomas D, Bauer A, Katus HA, Karle CA, and Kiesecker C
- Subjects
- Animals, Antidepressive Agents, Second-Generation administration & dosage, Cell Line, Dose-Response Relationship, Drug, Electrophysiology, Female, Humans, Inhibitory Concentration 50, Kidney cytology, Mianserin administration & dosage, Oocytes drug effects, Patch-Clamp Techniques methods, Toxicity Tests, Xenopus, Antidepressive Agents, Second-Generation toxicity, Ether-A-Go-Go Potassium Channels antagonists & inhibitors, Mianserin toxicity
- Abstract
The antidepressant mianserin exhibits a tetracyclic structure that is different from typical tricyclic antidepressants (TCA) and that of selective serotonin reuptake inhibitors. In comparison to the older TCA, mianserin has been shown to have a superior risk profile regarding proarrhythmic effects, both in vitro and in vivo. However, the underlying molecular electrophysiological basis has not been elucidated to date. Therefore, we studied the effects of mianserin on cardiac hERG potassium channels, the predominant target of drug-induced proarrhythmia. HERG channels were expressed in the Xenopus oocyte expression system and in human embryonic kidney (HEK) cells and currents were measured with two-microelectrode voltage-clamp and whole-cell patch-clamp, respectively. Mianserin inhibited hERG currents in a dose-dependent manner with an IC(50) of 3.2 micromol/l in HEK cells. Onset of blockade was slow and the inhibitory effect was not reversible upon wash-out of the drug. In hERG channel mutants, Y652A and F656A, lacking aromatic residues in the S6 domain, the effect of mianserin was significantly reduced in comparison to the wild type. Mianserin inhibited hERG currents in the open and inactivated state, but not in the closed states. HERG inactivation kinetics were significantly altered by mianserin without marked effects on channel activation kinetics. The inhibitory effect was not frequency dependent. In conclusion, mianserin is a low-affinity hERG-blocking agent. However, taken together with the lack of APD-prolongation shown in other studies, mianserin seems to have a good safety profile. Lack of consistent QT prolonging effects of mianserin in previous studies may therefore be linked to additional effects such as inhibition of other cardiac ion channels. However, as demonstrated by clinical case reports, mianserin can induce proarrhythmic effects in susceptible patients. Therefore, in patients with complex co-medication (i.e., additional hERG-blocking agents) and in patients with risk factors for acquired long QT syndrome as well as in cases of overdose, adequate monitoring should be recommended.
- Published
- 2008
- Full Text
- View/download PDF
7. Doxazosin induces apoptosis of cells expressing hERG K+ channels.
- Author
-
Thomas D, Bloehs R, Koschny R, Ficker E, Sykora J, Kiehn J, Schlömer K, Gierten J, Kathöfer S, Zitron E, Scholz EP, Kiesecker C, Katus HA, and Karle CA
- Subjects
- Adrenergic alpha-Antagonists pharmacology, Cell Line, Electrophysiology, Ether-A-Go-Go Potassium Channels metabolism, Flow Cytometry, Humans, In Situ Nick-End Labeling, Staining and Labeling, Antihypertensive Agents pharmacology, Apoptosis drug effects, Doxazosin pharmacology, Ether-A-Go-Go Potassium Channels drug effects
- Abstract
The antihypertensive drug doxazosin has been associated with an increased risk for congestive heart failure and cardiomyocyte apoptosis. Human ether-a-go-go-related gene (hERG) K(+) channels, previously shown to be blocked by doxazosin at therapeutically relevant concentrations, represent plasma membrane receptors for the antihypertensive drug. To elucidate the molecular basis for doxazosin-associated pro-apoptotic effects, cell death was studied in human embryonic kidney cells using three independent apoptosis assays. Doxazosin specifically induced apoptosis in hERG-expressing HEK cells, while untransfected control groups were insensitive to treatment with the antihypertensive agent. An unexpected biological mechanism has emerged: binding of doxazosin to its novel membrane receptor, hERG, triggers apoptosis, possibly representing a broader pathophysiological mechanism in drug-induced heart failure.
- Published
- 2008
- Full Text
- View/download PDF
8. Kir2.x inward rectifier potassium channels are differentially regulated by adrenergic alpha1A receptors.
- Author
-
Zitron E, Günth M, Scherer D, Kiesecker C, Kulzer M, Bloehs R, Scholz EP, Thomas D, Weidenhammer C, Kathöfer S, Bauer A, Katus HA, and Karle CA
- Subjects
- Animals, Calcium-Calmodulin-Dependent Protein Kinase Type 2 metabolism, Cyclic AMP-Dependent Protein Kinases metabolism, Heart Ventricles cytology, Heart Ventricles enzymology, Heart Ventricles metabolism, Myocytes, Cardiac enzymology, Myocytes, Cardiac metabolism, Potassium Channels, Inwardly Rectifying antagonists & inhibitors, Protein Kinase C metabolism, Proto-Oncogene Proteins pp60(c-src) metabolism, Rats, Xenopus, Ion Channel Gating, Potassium Channels, Inwardly Rectifying metabolism, Receptors, Adrenergic, alpha-1 metabolism
- Abstract
Inhibition of I(K1) currents by adrenergic alpha(1) receptors has been observed in cardiomyocytes and has been linked to arrhythmogenesis in an animal model. Both PKC-dependent and PKC-independent pathways have been implied in this regulation. The underlying molecular mechanisms, however, have not been elucidated to date. The molecular basis of native I(K1) current is mainly formed by Kir2.1 (KCNJ2), Kir2.2 (KCNJ12) and Kir2.3 (KCNJ4) channels that are differentially regulated by protein kinases. We therefore sought to investigate the role of those different Kir2.x channel subunits in this regulation and to identify the major signalling pathways involved. Adrenergic alpha(1A) receptors (the predominant cardiac isoform) were co-expressed with cloned Kir2.1, Kir2.2 and Kir2.3 channels in Xenopus oocytes and electrophysiological experiments were performed using two-microelectrode voltage clamp. Native I(K1) currents were measured with the whole-cell patch clamp technique in isolated rat ventricular cardiomyocytes. Activation of co-expressed adrenergic alpha(1A) receptors by phenylephrine induced differential effects in Kir2.x channels. No effect was noticed in Kir2.1 channels. However, a marked inhibitory effect was observed in Kir2.2 channels. This regulation was not attenuated by inhibitors of PKC, CamKII and PKA (chelerythrine, KN-93, KT-5720), and mutated Kir2.2 channels lacking functional phosphorylation sites for PKC and PKA exhibited the same effect as Kir2.2 wild-type channels. By contrast, the regulation could be suppressed by the general tyrosine kinase inhibitor genistein and by the src tyrosine kinase inhibitor PP2 indicating an essential role of src kinases. This finding was validated in rat ventricular cardiomyocytes where co-application of PP2 strongly attenuated the inhibitory regulation of I(K1) current by adrenergic alpha(1) receptors. The inactive analogue PP3 was tested as negative control for PP2 and did not reproduce the effects of PP2. In Kir2.3 channels, a marked inhibitory effect of alpha(1A) receptor activation was observed. This regulation could be attenuated by inhibition of PKC with chelerythrine or with Ro-32-0432, but not by tyrosine kinase inhibition with genistein. In summary, on the molecular level the inhibitory regulation of I(K1) currents by adrenergic alpha(1A) receptors is probably based on effects on Kir2.2 and Kir2.3 channels. Kir2.2 is regulated via src tyrosine kinase pathways independent of protein kinase C, whereas Kir2.3 is inhibited by protein kinase C-dependent pathways. Src tyrosine kinase pathways are essential for the inhibition of native I(K1) current by adrenergic alpha(1) receptors. This regulation may contribute to arrhythmogenesis under adrenergic stimulation.
- Published
- 2008
- Full Text
- View/download PDF
9. Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels.
- Author
-
Kelemen K, Kiesecker C, Zitron E, Bauer A, Scholz E, Bloehs R, Thomas D, Greten J, Remppis A, Schoels W, Katus HA, and Karle CA
- Subjects
- Animals, Catechin administration & dosage, Cells, Cultured, Dose-Response Relationship, Drug, ERG1 Potassium Channel, Ether-A-Go-Go Potassium Channels drug effects, Ion Channel Gating drug effects, Kidney drug effects, Oocytes drug effects, Xenopus laevis, Catechin analogs & derivatives, Ether-A-Go-Go Potassium Channels physiology, Ion Channel Gating physiology, Kidney physiology, Oocytes physiology, Potassium metabolism, Tea chemistry
- Abstract
The catechin EGCG is the main flavonoid compound of green tea and has received enormous pharmacological attention because of its putative beneficial health effects. This study investigated for the first time the effect of EGCG on hERG channels, the main pharmacological target of drugs that cause acquired long QT syndrome. Cloned hERG channels were expressed in Xenopus oocytes and in HEK293 cells. Heterologous hERG currents were inhibited by EGCG with an IC50 of 6.0 micromol/l in HEK293 cells and an IC50 of 20.5 micromol/l in Xenopus laevis oocytes. Onset of effect was slow and only little recovery from inhibition was observed upon washout. In X. laevis oocytes EGCG inhibited hERG channels in the open and inactivated states, but not in the closed states. The half-maximal activation voltage of hERG currents was shifted by EGCG towards more positive potentials. In conclusion, EGCG is a low-affinity inhibitor of hERG sharing major electrophysiological features with pharmaceutical hERG antagonists.
- Published
- 2007
- Full Text
- View/download PDF
10. Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656.
- Author
-
Scholz EP, Konrad FM, Weiss DL, Zitron E, Kiesecker C, Bloehs R, Kulzer M, Thomas D, Kathöfer S, Bauer A, Maurer MH, Seemann G, Katus HA, and Karle CA
- Subjects
- Animals, Cell Line, Cloning, Molecular, ERG1 Potassium Channel, Ether-A-Go-Go Potassium Channels genetics, Female, Humans, Mutation, Oocytes drug effects, Oocytes physiology, Xenopus laevis, Antiparkinson Agents pharmacology, Cholinergic Antagonists pharmacology, Ether-A-Go-Go Potassium Channels physiology, Orphenadrine pharmacology
- Abstract
The anticholinergic antiparkinson drug orphenadrine is an antagonist at central and peripheral muscarinic receptors. Orphenadrine intake has recently been linked to QT prolongation and Torsade-de-Pointes tachycardia. So far, inhibitory effects on I (Kr) or cloned HERG channels have not been examined. HERG channels were heterologously expressed in a HEK 293 cell line and in Xenopus oocytes and HERG current was measured using the whole cell patch clamp and the double electrode voltage clamp technique. Orphenadrine inhibits cloned HERG channels in a concentration dependent manner, yielding an IC(50) of 0.85 microM in HEK cells. Onset of block is fast and reversible upon washout. Orphenadrine does not alter the half-maximal activation voltage of HERG channels. There is no shift of the half-maximal steady-state-inactivation voltage. Time constants of direct channel inactivation are not altered significantly and there is no use-dependence of block. HERG blockade is attenuated significantly in mutant channels lacking either of the aromatic pore residues Y652 and F656. In conclusion, we show that the anticholinergic agent orphenadrine is an antagonist at HERG channels. These results provide a novel molecular basis for the reported proarrhythmic side effects of orphenadrine.
- Published
- 2007
- Full Text
- View/download PDF
11. Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656.
- Author
-
Scholz EP, Zitron E, Kiesecker C, Thomas D, Kathöfer S, Kreuzer J, Bauer A, Katus HA, Remppis A, Karle CA, and Greten J
- Subjects
- Amino Acids, Aromatic genetics, Animals, Dose-Response Relationship, Drug, ERG1 Potassium Channel, Hesperidin chemistry, Hesperidin metabolism, Mutation physiology, Oocytes drug effects, Patch-Clamp Techniques, Potassium Channel Blockers metabolism, Xenopus, Amino Acids, Aromatic metabolism, Cardiovascular Diseases prevention & control, Citrus sinensis chemistry, Ether-A-Go-Go Potassium Channels drug effects, Hesperidin pharmacology, Potassium Channel Blockers pharmacology
- Abstract
Background and Aims: Hesperetin belongs to the flavonoid subgroup classified as citrus flavonoids and is the main flavonoid in oranges. A high dietary intake of flavonoids has been associated with a significant reduction in cardiovascular mortality. HERG potassium channels play a major role in cardiac repolarisation and represent the most important pharmacologic target of both antiarrhythmic and proarrhythmic drugs., Methods and Results: We used the two-microelectrode voltage-clamp technique to analyse inhibitory effects of hesperetin on hERG potassium channels heterologously expressed in Xenopus oocytes. Hesperetin blocked hERG potassium channels in a concentration dependent manner. Onset of block was fast and completely reversible upon wash-out. There was no significant effect of hesperetin on channel kinetics. Affinity of hesperetin to mutant F656A hERG channel was significantly decreased compared to WT hERG, indicating a binding site in the channel pore cavity. In contrast, affinity of hesperetin to Y652A hERG was not different from the affinity to WT hERG., Conclusion: We found an antagonist of cardiac hERG channels that modulates hERG currents by accessing the aromatic pore binding site, particularly amino acid phe-656. Regarding high hesperetin concentrations found in oranges and the increasing consumption of oranges and orange juice in Europe, potential effects of hesperetin on cardiac electrophysiology in vivo deserve further investigation.
- Published
- 2007
- Full Text
- View/download PDF
12. Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2.
- Author
-
Scherer D, Kiesecker C, Kulzer M, Günth M, Scholz EP, Kathöfer S, Thomas D, Maurer M, Kreuzer J, Bauer A, Katus HA, Karle CA, and Zitron E
- Subjects
- Animals, Female, Oocytes physiology, Patch-Clamp Techniques, Potassium metabolism, Potassium Channel Blockers, Potassium Channels, Inwardly Rectifying genetics, Signal Transduction, Xenopus laevis, Cyclic AMP-Dependent Protein Kinases physiology, Potassium Channels, Inwardly Rectifying metabolism, Protein Kinase C physiology, Receptors, Adrenergic, beta-3 physiology
- Abstract
beta(3)-adrenoceptors have recently been shown to induce a complex modulation of intracellular signaling pathways including cyclic guanine monophosphate, cyclic adenosine monophosphate, nitric oxide, and protein kinases A and C. They are expressed in a broad variety of tissues including the myocardium, vascular smooth muscle, and endothelium. In those tissues, resting membrane potential is controlled mainly by inwardly rectifying potassium channels of the Kir2 family namely, Kir2.1 in the vascular smooth muscle, Kir2.1-2.3 in the myocardium, and Kir2.1-2.2 in the endothelium. In the present study, we investigated the possible modulation of Kir2 channel function by beta(3)-adrenoceptors in an expression system. Human-cloned beta(3)-adrenoceptors and Kir2.1 (KCNJ2), Kir2.2 (KCNJ12), and Kir2.3 (KCNJ4) channels were coexpressed in Xenopus oocytes, and currents were measured with double-microelectrode voltage clamp. Activation of beta(3)-adrenoceptors with isoproterenol resulted in markedly increased currents in Kir2.1 and in Kir2.2 potassium channels with EC50 values of 27 and 18 nM, respectively. In contrast, Kir2.3 currents were not modulated. Coapplication of specific inhibitors of protein kinase A (KT-5720) and calmodulin kinase II (KN-93) had no effects on the observed regulation in Kir2.1. However, coapplication of protein kinase C (PKC) inhibitors staurosporine and chelerythrine suppressed the observed effect. In Kir2.2, coapplication of KT-5720 reduced the effect of beta(3)-adrenoceptor activation. No differences in current increase after application of isoproterenol were observed between mutant Kir2.2 potassium channels lacking all functional PKC phosphorylation sites and Kir2.2 wild-type channels. In heteromeric Kir2.x channels, all types of heteromers were activated. The effect was most pronounced in Kir2.1/Kir2.2 and in Kir2.2/Kir2.3 channels. In summary, homomeric and heteromeric Kir2.x channels are activated by beta(3)-adrenoceptors via different protein kinase-dependent pathways: Kir2.1 subunits are modulated by PKC, whereas Kir2.2 is modulated by protein kinase A. In heteromeric composition, a marked activation of currents can be observed particularly with involvement of Kir2.2 subunits. This regulation may contribute to the hyperpolarizing effects of beta(3)-adrenoceptors in tissues that exhibit modulation by Kir2 channel function.
- Published
- 2007
- Full Text
- View/download PDF
13. In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform.
- Author
-
Scholz EP, Alter M, Zitron E, Kiesecker C, Kathöfer S, Thomas D, Kreye VA, Kreuzer J, Becker R, Katus HA, Greten J, and Karle CA
- Subjects
- Animals, Cell Line, Dose-Response Relationship, Drug, Ether-A-Go-Go Potassium Channels antagonists & inhibitors, Female, Kidney drug effects, Kidney embryology, Membrane Potentials drug effects, Oocytes drug effects, Patch-Clamp Techniques, Tachycardia, Ventricular metabolism, Xenopus laevis, Chloroform toxicity, Ether-A-Go-Go Potassium Channels metabolism, Solvents toxicity, Tachycardia, Ventricular chemically induced
- Abstract
Acute chloroform intoxication can cause depression of the central nervous system and may lead to death from lethal arrhythmias or respiratory arrest. Thus, the organic solvent is no longer in clinical use as an anaesthetic, but still plays a role in cases of suicide, homicide or inhalation for psychotropic effects. Several cases of lethal arrhythmia after intoxication with chloroform have been described. Pharmacological inhibition of cardiac "human ether-à-go-go-related gene" (HERG) potassium channels is linked to proarrhythmic effects of cardiac and noncardiac drugs. To further investigate the electrophysiological basis of the arrhythmogenic potential of chloroform, we analysed inhibitory effects of chloroform on cloned HERG potassium channels, heterologously expressed in Xenopus oocytes and in Human Embryonic Kidney (HEK 293) cells using the double-electrode voltage-clamp technique and the whole-cell patch-clamp technique, respectively. In HEK cells, chloroform blocked HERG tail currents with an IC(50) of 4.97mM. Biophysical properties were further investigated in the Xenopus oocyte expression system. Onset and wash-out of block was fast and inhibition was completely reversible. Chloroform did not alter channel activation, however, direct channel inactivation was accelerated significantly. Steady-state-inactivation of HERG was not affected. Chloroform dependent block of HERG channels was voltage dependent with a decrease of inhibition at more positive membrane potentials. No frequency-dependence of block could be observed. In summary, chloroform blocked HERG potassium channels probably in a toxicologically relevant concentration. These findings contribute to the pathophysiology of proarrhythmic effects in acute chloroform intoxication.
- Published
- 2006
- Full Text
- View/download PDF
14. Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
- Author
-
Kiesecker C, Alter M, Kathöfer S, Zitron E, Scholz EP, Thomas D, Kreuzer J, Katus HA, Bauer A, and Karle CA
- Subjects
- Animals, Antidepressive Agents chemistry, Cell Line, Electrophysiology, Ether-A-Go-Go Potassium Channels genetics, Ether-A-Go-Go Potassium Channels metabolism, Humans, Maprotiline chemistry, Molecular Structure, Mutation genetics, Oocytes drug effects, Oocytes metabolism, Patch-Clamp Techniques, Phenylalanine genetics, Phenylalanine metabolism, Polycyclic Compounds chemistry, Potassium Channel Blockers chemistry, Tyrosine genetics, Tyrosine metabolism, Xenopus laevis, Antidepressive Agents pharmacology, Ether-A-Go-Go Potassium Channels antagonists & inhibitors, Maprotiline pharmacology, Polycyclic Compounds pharmacology, Potassium Channel Blockers pharmacology
- Abstract
Maprotiline is an antidepressant compound with an atypical tetracyclic structure that is widely used in elderly patients due to its favourable side-effect profile. However, there have been reports of proarrhythmia associated with maprotiline and in vitro studies of its electrophysiological properties have been lacking. Therefore, we characterised the effects of maprotiline on cardiac hERG channels. hERG channels were expressed in HEK cells and in the Xenopus oocyte expression system. Currents were measured using a whole-cell patch clamp and a two-microelectrode voltage-clamp. Maprotiline inhibited hERG currents with an IC(50) of 8.2 micromol/l in HEK cells and 29.2 micromol/l in Xenopus oocytes. Onset of the effect was rather slow and took several minutes. No wash-out of effect was observed. Maprotiline blocked hERG channels in the open and inactivated states, but not in the closed states. In mutant hERG channels Y652A and F656A, the effect was markedly attenuated (hERG-F656A) or completely abolished (hERG-Y652A). Voltage dependence of hERG current activation and inactivation was not affected by maprotiline. hERG inactivation was accelerated at positive potentials. The effect of maprotiline on hERG currents was voltage-dependent with a marked reduction at a more positive potential. hERG blockade by maprotiline was not frequency-dependent. Maprotiline is an antagonist of cardiac hERG potassium channels that preferably accesses the putative pore binding site Y652/F656. Although the affinity of maprotiline to hERG channels is low, its use in patients with risk factors for acquired long QT syndrome should be monitored appropriately.
- Published
- 2006
- Full Text
- View/download PDF
15. Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1.
- Author
-
Kiesecker C, Zitron E, Scherer D, Lueck S, Bloehs R, Scholz EP, Pirot M, Kathöfer S, Thomas D, Kreye VA, Kiehn J, Borst MM, Katus HA, Schoels W, and Karle CA
- Subjects
- Aged, Alkaloids metabolism, Animals, Benzophenanthridines metabolism, Endothelin-1 genetics, Endothelin-1 pharmacology, Enzyme Inhibitors metabolism, Heart Atria cytology, Humans, Middle Aged, Myocytes, Cardiac cytology, Myocytes, Cardiac metabolism, Oocytes physiology, Patch-Clamp Techniques, Potassium metabolism, Potassium Channels, Inwardly Rectifying genetics, Protein Kinase C antagonists & inhibitors, Protein Kinase C metabolism, Protein Subunits genetics, Protein Subunits metabolism, Receptor, Endothelin A metabolism, Staurosporine metabolism, Xenopus laevis, Endothelin-1 physiology, Myocytes, Cardiac drug effects, Potassium Channels, Inwardly Rectifying metabolism, Tachycardia metabolism
- Abstract
To elucidate the ionic mechanism of endothelin-1 (ET-1)-induced focal ventricular tachyarrhythmias, the regulation of I(K1) and its main molecular correlates, Kir2.1, Kir2.2 and Kir2.3 channels, by ET-1 was investigated. Native I(K1) in human atrial cardiomyocytes was studied with whole-cell patch clamp. Human endothelin receptors were coexpressed with human Kir2.1, Kir2.2 and Kir2.3 channels in Xenopus oocytes. Currents were measured with a two-microelectrode voltage clamp. In human cardiomyocytes, ET-1 induced a marked inhibition of I(K1) that could be suppressed by the protein kinase C (PKC) inhibitor staurosporine. To investigate the molecular mechanisms underlying this regulation, we studied the coupling of ET(A) receptors to homomeric and heteromeric Kir2.1, Kir2.2 and Kir2.3 channels in the Xenopus oocyte expression system. ET(A) receptors coupled functionally to Kir2.2 and Kir2.3 channels but not to Kir2.1 channels. In Kir2.2 channels lacking functional PKC phosphorylation sites, the inhibitory effect was abolished. The inhibition of Kir2.3 currents could be suppressed by the PKC inhibitors staurosporine and chelerythrine. The coupling of ET(A) receptors to heteromeric Kir2.1/Kir2.2 and Kir2.2/Kir2.3 channels resulted in a strong inhibition of currents comparable with the effect observed in Kir2.2 homomers. Surprisingly, in heteromeric Kir2.1/Kir2.3 channels, no effect was observed. ET-1 inhibits human cardiac I(K1) current via a PKC-mediated phosphorylation of Kir2.2 channel subunits and additional regulatory effects on Kir2.3 channels. This mechanism may contribute to the intrinsic arrhythmogenic potential of ET-1.
- Published
- 2006
- Full Text
- View/download PDF
16. Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarisation.
- Author
-
Scholz EP, Zitron E, Kiesecker C, Lück S, Thomas D, Kathöfer S, Kreye VA, Katus HA, Kiehn J, Schoels W, and Karle CA
- Subjects
- Animals, Diet, Ether-A-Go-Go Potassium Channels genetics, Ether-A-Go-Go Potassium Channels physiology, Heart physiology, Mutation, Oocytes drug effects, Oocytes physiology, Patch-Clamp Techniques, Xenopus, Citrus paradisi chemistry, Ether-A-Go-Go Potassium Channels drug effects, Flavanones pharmacology
- Abstract
Flavonoids are naturally occurring food ingredients that have been associated with reduced cardiovascular mortality in epidemiological studies. In a previous study, we demonstrated for the first time that flavonoids are inhibitors of cardiac human ether-à-go-go-related gene (HERG) channels. Furthermore, we observed that grapefruit juice induced mild QTc prolongation in healthy subjects. HERG blockade by grapefruit flavonoid naringenin is most likely to be the mechanism underlying this effect. Therefore, the electrophysiological properties of HERG blockade by naringenin were analysed in detail. HERG potassium currents expressed in Xenopus oocytes were measured with a two-microelectrode voltage clamp. Naringenin blocked HERG potassium channels with an IC50 value of 102.6 microM in Xenopus oocytes. The onset of blockade was fast. The effect was completely reversible upon wash-out. Naringenin binding to HERG required aromatic residue F656 in the putative pore binding site. Channels were blocked in the open and inactivated states but not in the closed states. Naringenin did not affect HERG current activation. However, the half maximal inactivation voltage was shifted by 14.9 mV towards more negative potentials and current inactivation at negative potentials was accelerated. No frequency dependence of blockade was observed. Naringenin inhibits HERG channels with pharmacological characteristics similar to those of well-known HERG antagonists. From a clinical point of view, this effect could have both proarrhythmic and antiarrhythmic consequences. This may have important implications for phytotherapy and for dietary recommendations for cardiologic patients. Therefore, electrophysiological effects of flavonoids deserve further investigation.
- Published
- 2005
- Full Text
- View/download PDF
17. Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.
- Author
-
Kiesecker C, Zitron E, Lück S, Bloehs R, Scholz EP, Kathöfer S, Thomas D, Kreye VA, Katus HA, Schoels W, Karle CA, and Kiehn J
- Subjects
- Action Potentials physiology, Ajmaline chemistry, Animals, Anti-Arrhythmia Agents chemistry, Cell Line, Dose-Response Relationship, Drug, ERG1 Potassium Channel, Ether-A-Go-Go Potassium Channels, Female, Humans, Potassium Channels, Voltage-Gated physiology, Xenopus laevis, Action Potentials drug effects, Ajmaline pharmacology, Anti-Arrhythmia Agents pharmacology, Potassium Channels, Voltage-Gated antagonists & inhibitors
- Abstract
Ajmaline is a class Ia anti-arrhythmic drug used in several European countries and Japan as first-line treatment for ventricular tachyarrhythmia. Ajmaline has been reported to induce cardiac output (QT) prolongation and to inhibit cardiac potassium currents in guinea pig cardiomyocytes. In order to elucidate the molecular basis of these effects, we examined effects of ajmaline on human ether a-go-go related gene HERG potassium channels. Electrophysiological experiments were performed with human embryonic kidney (HEK) cells (whole-cell patch clamp) and Xenopus oocytes (double-electrode voltage clamp) expressing wild-type and mutant HERG channels. Ajmaline blocked HERG currents with an IC(50) of 1.0 micromol/l in HEK cells and 42.3 micromol/l in Xenopus oocytes. The onset of block was fast and reached steady-state conditions after 180 s. The inhibitory effect was completely reversible upon wash-out. In HERG mutant channels Y652A and F656A lacking aromatic residues in the S6 domain, the inhibitory effect of ajmaline was completely abolished. Ajmaline induced a small shift in HERG current half-maximal activation voltage towards more negative potentials. Ajmaline did not markedly affect HERG inactivation. Inhibitory effects were not voltage-dependent. Ajmaline block exhibited positive frequency dependence. Ajmaline blocked HERG channels in the open, but not in the closed states. Binding of ajmaline to inactivated HERG channels may also be possible. In inactivation-deficient HERG S620T channels, the sensitivity to ajmaline was markedly reduced. The IC(50) of HERG channel blockade in HEK cells lies within the range of unbound therapeutic plasma concentrations of ajmaline. Therefore, inhibitory effects on HERG channels may contribute to both the high anti-arrhythmic efficacy of ajmaline and to its pro-arrhythmic potential.
- Published
- 2004
- Full Text
- View/download PDF
18. Human cardiac inwardly rectifying current IKir2.2 is upregulated by activation of protein kinase A.
- Author
-
Zitron E, Kiesecker C, Lück S, Kathöfer S, Thomas D, Kreye VA, Kiehn J, Katus HA, Schoels W, and Karle CA
- Subjects
- Animals, Enzyme Activation, Female, Humans, Long QT Syndrome metabolism, Male, Oocytes metabolism, Patch-Clamp Techniques, Potassium Channels, Inwardly Rectifying genetics, Protein Kinase C metabolism, Xenopus, Cyclic AMP-Dependent Protein Kinases metabolism, Ion Channel Gating physiology, Myocardium metabolism, Potassium Channels, Inwardly Rectifying metabolism
- Abstract
Objective: The cardiac inwardly rectifying potassium current IK1 and its molecular correlates Kir2.1 and Kir2.2 play an important role in cardiac repolarisation and in the pathogenesis of hereditary long-QT syndrome (LQTS-7). Protein kinases A (PKA) and C (PKC) are key enzymes in adrenergic signal transduction, inducing arrhythmias in heart disease. This study investigated the regulation of Kir2.2 (KCNJ12) by PKA., Methods: Cloned Kir2.2 channels were expressed heterologously in Xenopus oocytes and currents were measured with the double-electrode voltage-clamp technique., Results: After activation of PKA by forskolin (100 micromol/l) or Ro-20-1724 (100 micromol/l), wild type currents at -120 mV were increased by 93.7% and 79.0%, respectively. Coapplication of the PKA inhibitor KT-5720 (2.5 micromol/l) attenuated this effect. No significant changes were apparent after mutation of the single PKA consensus site S430. In addition, removal of all four PKC consensus sites in Kir2.2 induced a phorbolester-mediated current increase which could be suppressed by PKA inhibitors H-89 (50 micromol/l) and KT-5720 (2.5 micromol/l)., Conclusions: This study demonstrates antagonistic effects of PKA and PKC in the regulation of Kir2.2. Phosphorylation by PKC has been shown to cause an inhibition of Kir2.2 currents, whereas activation of PKA leads to current upregulation., (Copryright 2004 European Society of Cardiology)
- Published
- 2004
- Full Text
- View/download PDF
19. Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone.
- Author
-
Zitron E, Kiesecker C, Scholz E, Lück S, Bloehs R, Kathöfer S, Thomas D, Kiehn J, Kreye VA, Katus HA, Schoels W, and Karle CA
- Subjects
- Animals, Cell Line, Dose-Response Relationship, Drug, ERG1 Potassium Channel, Ether-A-Go-Go Potassium Channels, Humans, Ion Channel Gating, Membrane Potentials drug effects, Mutation, Myocardium, Oocytes drug effects, Oocytes physiology, Patch-Clamp Techniques, Potassium Channels, Voltage-Gated biosynthesis, Potassium Channels, Voltage-Gated genetics, Time Factors, Xenopus laevis, Antidepressive Agents, Second-Generation pharmacology, Potassium Channel Blockers pharmacology, Potassium Channels, Voltage-Gated physiology, Trazodone pharmacology
- Abstract
Trazodone is an atypical antidepressant that is commonly used in the treatment of affective disorders. There have repeatedly been reports of cardiac arrhythmia associated with this drug and concerns have been raised regarding the cardiac safety of trazodone. However, interaction with HERG channels as a main factor of cardiac side effects has not been studied to date. Therefore, we investigated the effect of trazodone on HERG potassium channels expressed in human embryonic kidney (HEK) cells and in Xenopus oocytes. Trazodone inhibited HERG currents in a dose-dependent manner with an IC50 of 2.9 microM in HEK cells and 13.2 microM in Xenopus oocytes. The electrophysiological properties of HERG blockade were analysed in detail. In HERG channel mutants Y652A and F656A lacking aromatic residues in the S6 domain, the affinity of trazodone was reduced profoundly. Trazodone accelerated inactivation of HERG currents without markedly affecting activation. Blockade was voltage dependent with a small reduction of block at positive membrane potentials. Frequency dependence of block was not observed. Trazodone block of HERG channels was state dependent. Channels were affected in the activated and inactivated states, but not in the closed states. In summary, the atypical antidepressant trazodone blocks cardiac HERG channels at concentrations that are probably relevant in vivo, particularly in overdosage.
- Published
- 2004
- Full Text
- View/download PDF
20. Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.
- Author
-
Scholz EP, Zitron E, Kiesecker C, Lueck S, Kathöfer S, Thomas D, Weretka S, Peth S, Kreye VA, Schoels W, Katus HA, Kiehn J, and Karle CA
- Subjects
- Animals, Binding Sites, Calcium Channels drug effects, Calcium Channels physiology, Ether-A-Go-Go Potassium Channels, Guinea Pigs, In Vitro Techniques, Myocytes, Cardiac drug effects, Myocytes, Cardiac metabolism, Oocytes drug effects, Patch-Clamp Techniques, Potassium Channels physiology, Time Factors, Xenopus laevis, Antiparkinson Agents adverse effects, Cation Transport Proteins, Long QT Syndrome metabolism, Piperidines adverse effects, Potassium Channels metabolism, Potassium Channels, Voltage-Gated
- Abstract
Budipine is a non-dopaminergic antiparkinsonian drug causing acquired forms of Long QT syndrome (aLQTS). As a consequence, the manufacturer has restricted the use of budipine in patients who exhibit additional risk factors for the development of "Torsades-de-Pointes" tachycardias (TdP). The molecular basis of this serious side effect has not been elucidated yet. Human ether-a-go-go related gene (HERG) channel block being the main cause of drug induced QT prolongation, we investigated the effect of budipine on the rapid component of the delayed-rectifier potassium current (I(K(r))) in guinea pig cardiomyocytes and on HERG potassium channels heterologously expressed in Xenopus oocytes. In guinea pig cardiomyocytes, budipine (10 microM) inhibited I(K(r)) by 86% but was without any effect on calcium currents. In Xenopus oocytes, HERG potassium channels were blocked by budipine with an IC(50) of 10.2 microM. Onset of block was fast and block was only slowly and incompletely reversible upon washout. Budipine blocked HERG channels in the open and inactivated state, but not in the closed states. The half-maximal activation voltage was slightly shifted towards more negative potentials. Steady-state inactivation of HERG was also influenced by budipine. Budipine block was neither voltage- nor frequency-dependent. In HERG channel mutants Y652A and F656A, drug affinity was reduced dramatically. Therefore, these two aromatic residues in the channel pore are likely to form a main part of the binding site for budipine. In summary, this is the first study that provides a molecular basis for the budipine-associated aLQTS observed in clinical practice. Furthermore, these findings underline the importance of the aromatic residues Y652 and F656 in the binding of lipophilic drugs to HERG channels.
- Published
- 2003
- Full Text
- View/download PDF
21. Isolation, characterization, and cloning of porcine complement component C7.
- Author
-
Agah A, Montalto MC, Kiesecker CL, Morrissey M, Grover M, Whoolery KL, Rother RP, and Stahl GL
- Subjects
- Amino Acid Sequence, Animals, Cloning, Molecular, Complement C7 genetics, Complement C7 metabolism, Complement Hemolytic Activity Assay, DNA, Complementary isolation & purification, Humans, Molecular Sequence Data, Organ Specificity genetics, Organ Specificity immunology, Precipitin Tests, Rabbits, Rats, Sequence Homology, Amino Acid, Structure-Activity Relationship, Swine genetics, Complement C7 chemistry, Complement C7 isolation & purification, Swine immunology
- Abstract
Activation of the complement system through the classical, alternative, or lectin pathway results in the formation of the terminal complement complex. C7 plays an integral role in the assembly of this complex with target cell membranes. To date, only human C7 has been cloned and characterized; thus, in this study, we characterized the porcine complement component C7. Porcine C7 was isolated by affinity chromatography as a single glycoprotein with an approximate molecular mass of 90 kDa and 100 kDa under reducing and nonreducing conditions, respectively. The full-length porcine C7 cDNA was isolated, and the predicted amino acid sequence exhibited 80% identity with human C7 with conservation of the cysteine backbone and two putative N-linked glycosylation sites. Porcine C7 mRNA expression was detected in all tissues investigated, except polymorphonuclear and mononuclear leukocytes. Addition of purified porcine C7 restored the hemolytic activity of C7-depleted human sera in a dose-dependent manner. A functionally inhibitory mAb against porcine C7 attenuated the hemolytic activity of human, rabbit, or rat sera, suggesting an important conserved C7 epitope among species. These data demonstrate that porcine and human C7 are highly conserved, sharing structural and functional characteristics.
- Published
- 2000
- Full Text
- View/download PDF
22. Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1.
- Author
-
Faas SJ, Giannoni MA, Mickle AP, Kiesecker CL, Reed DJ, Wu D, Fodor WL, Mueller JP, Matis LA, and Rother RP
- Subjects
- Abatacept, Adult, Amino Acid Sequence, Animals, Antigens, CD, Antigens, Differentiation metabolism, Antigens, Heterophile immunology, B7-1 Antigen biosynthesis, B7-1 Antigen genetics, Base Sequence, Blotting, Northern, CD28 Antigens metabolism, CTLA-4 Antigen, Cells, Cultured, Cloning, Molecular, Dimerization, Humans, Immunosuppressive Agents pharmacology, Interleukin-2 antagonists & inhibitors, Interleukin-2 biosynthesis, Isoantigens immunology, Jurkat Cells, Lymphocyte Activation, Lymphocyte Culture Test, Mixed, Membrane Proteins biosynthesis, Membrane Proteins chemistry, Molecular Sequence Data, Protein Binding, Solubility, Swine, T-Lymphocytes immunology, T-Lymphocytes metabolism, Alternative Splicing immunology, B7-1 Antigen chemistry, B7-1 Antigen physiology, Immunoconjugates
- Abstract
Recent studies have suggested that soluble forms of B7-1 and B7-2 may exist, but transcripts that code for these molecules have not been previously described. In this study, we report the cloning and characterization of an alternatively spliced soluble form of porcine B7-1 (sB7-1) that lacks exons coding for both the transmembrane and cytoplasmic domains. Northern blot analysis of RNA from alveolar macrophages revealed an approximate 3:1 ratio of the transmembrane form of B7-1 mRNA relative to sB7-1 mRNA. Porcine B7-1 was present on the surface of both B and T cells following stimulation with PMA/ionomycin. A histidine-tagged form of porcine sB7-1 (sB7-1-His) interacted with both CD28 and CTLA-4, and effectively blocked IL-2 production from human responder cells stimulated with PHA and either porcine or human stimulator cells. In addition, sB7-1-His inhibited human T cell proliferation in response to porcine or human peripheral blood leukocytes. This study is the first report of an alternatively spliced form of B7 that codes for a soluble protein. Furthermore, these data demonstrate that porcine B7-1 interacts with the human receptors CD28 and CTLA-4, suggesting a potential role for this molecule in pig to human xenotransplantation. Possible physiological functions for the soluble form of B7-1 are discussed.
- Published
- 2000
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.